JeremiahWoon
2021-02-19
But why is Pfizer stock price still zzzz.. sigh
Study in Israel shows Pfizer vaccine 85% effective after first dose - The Lancet
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":387009876,"tweetId":"387009876","gmtCreate":1613696021495,"gmtModify":1634552624525,"author":{"id":3570311016208932,"idStr":"3570311016208932","authorId":3570311016208932,"authorIdStr":"3570311016208932","name":"JeremiahWoon","avatar":"https://static.tigerbbs.com/f9ff9fdefc613c6f5a4c8cd0c74ea082","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>But why is Pfizer stock price still zzzz.. sigh</p></body></html>","htmlText":"<html><head></head><body><p>But why is Pfizer stock price still zzzz.. sigh</p></body></html>","text":"But why is Pfizer stock price still zzzz.. sigh","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/387009876","repostId":2112897040,"repostType":2,"repost":{"id":"2112897040","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613695655,"share":"https://www.laohu8.com/m/news/2112897040?lang=&edition=full","pubTime":"2021-02-19 08:47","market":"us","language":"en","title":"Study in Israel shows Pfizer vaccine 85% effective after first dose - The Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2112897040","media":"Reuters","summary":"Feb 18 (Reuters) - The first dose of Pfizer Inc and BioNTech's COVID-19 vaccine is 85% effecti","content":"<html><body><p>Feb 18 (Reuters) - The first dose of Pfizer Inc and BioNTech's COVID-19 vaccine is 85% effective, a study of Israeli healthcare workers published in The Lancet </p><p>medical journal has found.</p><p> The research was conducted on more than 7,000 healthcare workers who were vaccinated at the Sheba Medical Centre in Israel. Researchers saw an 85% reduction of symptomatic COVID-19 between 15 and 28 days after they were given the vaccine.</p><p> Overall infections, including among asymptomatic patients, were reduced by 75%.</p><p> Pfizer in an emailed statement said it was looking at real world data from Israel and other locations to understand the impact of its vaccine against COVID-19 arising from emerging variants.</p><p> The Lancet publication comes a day after Canadian researchers suggested that the second Pfizer dose be delayed given the high level of protection from the first shot in order to increase the number of people getting vaccinated.</p><p> (Reporting by Derek Francis in Bengaluru; Editing by Jacqueline Wong)</p><p>((Derek.francis@thomsonreuters.com))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Study in Israel shows Pfizer vaccine 85% effective after first dose - The Lancet</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStudy in Israel shows Pfizer vaccine 85% effective after first dose - The Lancet\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-19 08:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Feb 18 (Reuters) - The first dose of Pfizer Inc and BioNTech's COVID-19 vaccine is 85% effective, a study of Israeli healthcare workers published in The Lancet </p><p>medical journal has found.</p><p> The research was conducted on more than 7,000 healthcare workers who were vaccinated at the Sheba Medical Centre in Israel. Researchers saw an 85% reduction of symptomatic COVID-19 between 15 and 28 days after they were given the vaccine.</p><p> Overall infections, including among asymptomatic patients, were reduced by 75%.</p><p> Pfizer in an emailed statement said it was looking at real world data from Israel and other locations to understand the impact of its vaccine against COVID-19 arising from emerging variants.</p><p> The Lancet publication comes a day after Canadian researchers suggested that the second Pfizer dose be delayed given the high level of protection from the first shot in order to increase the number of people getting vaccinated.</p><p> (Reporting by Derek Francis in Bengaluru; Editing by Jacqueline Wong)</p><p>((Derek.francis@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2112897040","content_text":"Feb 18 (Reuters) - The first dose of Pfizer Inc and BioNTech's COVID-19 vaccine is 85% effective, a study of Israeli healthcare workers published in The Lancet medical journal has found. The research was conducted on more than 7,000 healthcare workers who were vaccinated at the Sheba Medical Centre in Israel. Researchers saw an 85% reduction of symptomatic COVID-19 between 15 and 28 days after they were given the vaccine. Overall infections, including among asymptomatic patients, were reduced by 75%. Pfizer in an emailed statement said it was looking at real world data from Israel and other locations to understand the impact of its vaccine against COVID-19 arising from emerging variants. The Lancet publication comes a day after Canadian researchers suggested that the second Pfizer dose be delayed given the high level of protection from the first shot in order to increase the number of people getting vaccinated. (Reporting by Derek Francis in Bengaluru; Editing by Jacqueline Wong)((Derek.francis@thomsonreuters.com))","news_type":1},"isVote":1,"tweetType":1,"viewCount":43,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":39,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/387009876"}
精彩评论